Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Amberlyst 15 catalyzed route for Bisolvon reduces toxicity and steps. Offers cost reduction in pharmaceutical manufacturing and high-purity API intermediate supply.
Patent CN101585788A reveals mild gold-catalyzed route for allyl sulfonamides, offering high purity and scalable cinnamaldehyde precursor synthesis.
Patent CN103755634A reveals a novel synthetic route for hyperfluorescent 9-aminoacridine derivatives, offering scalable manufacturing and superior quantum yields for display applications.
Patent CN108640884B details a cost-effective 2-morpholinone synthesis. Discover high-purity pharmaceutical intermediates and scalable manufacturing solutions.
Patent CN108866021B details a novel transaminase mutant for synthesizing sitagliptin intermediates with >99% ee. Discover cost-effective biocatalytic solutions for API manufacturing.
Patent CN111549008B reveals a novel AcATA mutant for sitagliptin intermediate synthesis, offering superior conversion rates and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN111689881A reveals a catalytic sulfonation method for 4-chloro-2-fluoro-5-sulfamoylbenzoic acid, offering high purity and yield for reliable pharmaceutical intermediate supply chains.
Patent CN108178761A reveals a mild PtO2 catalytic route for Sitagliptin. This method offers significant cost reduction and supply chain reliability for API manufacturing.
Patent CN113583992A reveals a novel RsRedAm enzyme for efficient secondary amine synthesis, offering mild conditions and high selectivity for pharmaceutical intermediates.
Discover novel pyrimidine derivatives via Suzuki coupling. Enhance your pipeline with high-purity intermediates and cost-effective manufacturing solutions.
Patent CN111689933B details a green one-pot reductive amination using biomass-derived HMF and nitrobenzene, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.
Novel chiral induction method for Rotigotine intermediate. Reduces cost and improves scalability for pharmaceutical manufacturing supply chains globally.
Patent CN117756644A reveals a novel method converting caprolactam by-products into high-purity N-hexylcyclohexylamine, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Discover the novel cobalt-catalyzed reductive amination route for Vonoprazan Fumarate. Enhanced yield, simplified process, and cost-effective manufacturing for global supply chains.
Advanced synthesis of chiral tetrahydroquinoline derivatives via diastereomeric resolution. Reliable supplier for scalable API intermediates with optimized cost structures.
Novel intermediates for antidiabetic agents. Optimized synthesis routes reduce costs and improve supply chain reliability for global pharmaceutical manufacturers.
Patent CN117003647A details a Ru-Co alloy catalyst for low-temperature reductive amination, offering high yield and cost efficiency for pharmaceutical intermediate manufacturing.
Discover a novel, high-yield synthesis route for Prucalopride intermediates via reductive amination. Optimize your supply chain with cost-effective pharmaceutical manufacturing solutions.
Patent CN109704980A reveals a two-step route for Elagolix intermediates. Discover cost reduction in API intermediate manufacturing and supply chain reliability.
High-yield reductive amination route for Elagolix intermediate. Reduces impurities and enhances supply chain reliability for pharmaceutical manufacturing.